Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China

Zhijie An; Fuzhen Wang; An Pan; Zundong Yin; Lance Rodewald; Zijian Feng

doi:10.1136/bmj-2021-066125

Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China

BMJ. 2021 Dec 1:375:e066125. doi: 10.1136/bmj-2021-066125.

Authors

Zhijie An¹, Fuzhen Wang¹, An Pan², Zundong Yin¹, Lance Rodewald¹, Zijian Feng^{3

4}

Affiliations

¹ National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
² School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
³ National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China fengzj@chinacdc.cn.
⁴ Chinese Preventive Medicine Association, Beijing, China.

Abstract

Zijian Feng and colleagues argue that sustained elimination of SARS-CoV-2 in China offers flexibility in covid-19 vaccination policy and discuss the anticipated challenges and systematic monitoring necessary to keep the immunisation component of the response on track

MeSH terms

COVID-19 / epidemiology
COVID-19 / immunology*
COVID-19 / prevention & control*
COVID-19 Vaccines / immunology*
China / epidemiology
Humans
Mass Vaccination / organization & administration*
Mass Vaccination / statistics & numerical data
Pandemics
Quarantine
Risk Assessment
SARS-CoV-2

Substances

COVID-19 Vaccines